Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada

Kevin RobertsonDepartment of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Carmen BayonHospital La Paz, IdiPaz, Madrid, Spain

Jean-Michel MolinaDepartment of Infectious Diseases, University of Paris Sorbonne Cité and Hospital Saint-Louis, AP-HP, Paris, France;Department of Infectious Diseases, The University of Paris Diderot, Paris, France

Patricia McNamaraSt. James's Hospital, Dublin, Ireland

Christiane ReschInselspital, Bern University Hospital and University of Bern, Bern, Switzerland

Jose A. Muñoz-MorenoLluita contra la SIDA Foundation – Germans Trias i Pujol University Hospital, Barcelona, Spain

Ranjababu KulasegaramGuy's and St. Thomas' NHS Foundation Trust, London, UK

Knud ScheweInfektionsmedizinisches Centrum Hamburg (ICH), Hamburg, Germany

Angel Burgos-RamirezAbbVie, Madrid, Spain

Cristina De AlvaroAbbVie, Madrid, Spain

Esther CabreroAbbVie, Madrid, Spain

Matthew GuionAbbVie Inc., North Chicago, IL, USA

Michael NortonAbbVie Inc., North Chicago, IL, USA

Jean van WykAbbVie Inc., North Chicago, IL, USACorrespondence[email protected]

show all

Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada

Supplementary_Material.rar

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada

Supplementary_Material.rar

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date